Effects of lipoic acid on migration of human B cells and monocyte-enriched peripheral blood mononuclear cells in relapsing remitting multiple sclerosis

Joshua D. George; Edward Kim; Rebecca Spain; Dennis Bourdette; Sonemany Salinthone

doi:10.1016/j.jneuroim.2017.12.009

Effects of lipoic acid on migration of human B cells and monocyte-enriched peripheral blood mononuclear cells in relapsing remitting multiple sclerosis

Joshua D. George, Edward Kim, Rebecca Spain, Dennis Bourdette, Sonemany Salinthone

Neurology

Research output: Contribution to journal › Article › peer-review

3 Scopus citations

Abstract

Multiple sclerosis (MS) is a disease of the central nervous system characterized by inflammation and demyelination resulting in clinical disability. The rodent MS model suggests that infiltration of monocytes and B cells contributes to disease pathogenesis. Here, we compared the migratory capacity of human monocytes and B cells from healthy control (HC) and relapsing-remitting MS (RRMS) subjects, with or without lipoic acid (LA) treatment. Basal migration of monocyte-enriched PBMCs from RRMS subjects is significantly higher than HC PBMCs. LA treatment significantly inhibits monocyte and B cell migration in both cohorts, and may thus be therapeutically effective for treatment of MS.

Original language	English (US)
Pages (from-to)	24-27
Number of pages	4
Journal	Journal of Neuroimmunology
Volume	315
DOIs	https://doi.org/10.1016/j.jneuroim.2017.12.009
State	Published - Feb 15 2018

Keywords

B cell
Lipoic acid
Migration
Monocyte
RRMS

ASJC Scopus subject areas

Immunology and Allergy
Immunology
Neurology
Clinical Neurology

Access to Document

10.1016/j.jneuroim.2017.12.009

Fingerprint Dive into the research topics of 'Effects of lipoic acid on migration of human B cells and monocyte-enriched peripheral blood mononuclear cells in relapsing remitting multiple sclerosis'. Together they form a unique fingerprint.

Cite this

Effects of lipoic acid on migration of human B cells and monocyte-enriched peripheral blood mononuclear cells in relapsing remitting multiple sclerosis. / George, Joshua D.; Kim, Edward ; Spain, Rebecca ; Bourdette, Dennis; Salinthone, Sonemany.

In: Journal of Neuroimmunology, Vol. 315, 15.02.2018, p. 24-27.

Research output: Contribution to journal › Article › peer-review

@article{e3284097f716487ab9dc8ecd30c5eeb3,

title = "Effects of lipoic acid on migration of human B cells and monocyte-enriched peripheral blood mononuclear cells in relapsing remitting multiple sclerosis",

abstract = "Multiple sclerosis (MS) is a disease of the central nervous system characterized by inflammation and demyelination resulting in clinical disability. The rodent MS model suggests that infiltration of monocytes and B cells contributes to disease pathogenesis. Here, we compared the migratory capacity of human monocytes and B cells from healthy control (HC) and relapsing-remitting MS (RRMS) subjects, with or without lipoic acid (LA) treatment. Basal migration of monocyte-enriched PBMCs from RRMS subjects is significantly higher than HC PBMCs. LA treatment significantly inhibits monocyte and B cell migration in both cohorts, and may thus be therapeutically effective for treatment of MS.",

keywords = "B cell, Lipoic acid, Migration, Monocyte, RRMS",

author = "George, {Joshua D.} and Edward Kim and Rebecca Spain and Dennis Bourdette and Sonemany Salinthone",

note = "Funding Information: We would like to thank Sarah Fiedler for her help editing and general guidance. This work was supported by a Biomedical Laboratory Research and Development Service Merit Review ( 1I01BX001793 ), from the United States Department of Veterans Affairs. Oregon Clinical and Translational Institute (OCTRI) provided clinical coordination and nursing services with the support of National Institutes of Health (NIH) grant UL1TR000128 from the National Center for Advancing Translational Sciences (NCATS). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. ",

year = "2018",

month = feb,

day = "15",

doi = "10.1016/j.jneuroim.2017.12.009",

language = "English (US)",

volume = "315",

pages = "24--27",

journal = "Journal of Neuroimmunology",

issn = "0165-5728",

publisher = "Elsevier",

}

TY - JOUR

T1 - Effects of lipoic acid on migration of human B cells and monocyte-enriched peripheral blood mononuclear cells in relapsing remitting multiple sclerosis

AU - George, Joshua D.

AU - Kim, Edward

AU - Spain, Rebecca

AU - Bourdette, Dennis

AU - Salinthone, Sonemany

N1 - Funding Information: We would like to thank Sarah Fiedler for her help editing and general guidance. This work was supported by a Biomedical Laboratory Research and Development Service Merit Review ( 1I01BX001793 ), from the United States Department of Veterans Affairs. Oregon Clinical and Translational Institute (OCTRI) provided clinical coordination and nursing services with the support of National Institutes of Health (NIH) grant UL1TR000128 from the National Center for Advancing Translational Sciences (NCATS). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.

PY - 2018/2/15

Y1 - 2018/2/15

N2 - Multiple sclerosis (MS) is a disease of the central nervous system characterized by inflammation and demyelination resulting in clinical disability. The rodent MS model suggests that infiltration of monocytes and B cells contributes to disease pathogenesis. Here, we compared the migratory capacity of human monocytes and B cells from healthy control (HC) and relapsing-remitting MS (RRMS) subjects, with or without lipoic acid (LA) treatment. Basal migration of monocyte-enriched PBMCs from RRMS subjects is significantly higher than HC PBMCs. LA treatment significantly inhibits monocyte and B cell migration in both cohorts, and may thus be therapeutically effective for treatment of MS.

AB - Multiple sclerosis (MS) is a disease of the central nervous system characterized by inflammation and demyelination resulting in clinical disability. The rodent MS model suggests that infiltration of monocytes and B cells contributes to disease pathogenesis. Here, we compared the migratory capacity of human monocytes and B cells from healthy control (HC) and relapsing-remitting MS (RRMS) subjects, with or without lipoic acid (LA) treatment. Basal migration of monocyte-enriched PBMCs from RRMS subjects is significantly higher than HC PBMCs. LA treatment significantly inhibits monocyte and B cell migration in both cohorts, and may thus be therapeutically effective for treatment of MS.

KW - B cell

KW - Lipoic acid

KW - Migration

KW - Monocyte

KW - RRMS

UR - http://www.scopus.com/inward/record.url?scp=85039758996&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85039758996&partnerID=8YFLogxK

U2 - 10.1016/j.jneuroim.2017.12.009

DO - 10.1016/j.jneuroim.2017.12.009

M3 - Article

C2 - 29306401

AN - SCOPUS:85039758996

VL - 315

SP - 24

EP - 27

JO - Journal of Neuroimmunology

JF - Journal of Neuroimmunology

SN - 0165-5728

ER -